Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis

Jochen M. Schmitt, Daniel E. Ford

Research output: Contribution to journalArticlepeer-review

Abstract

Background: According to current guidelines the cost of productivity loss should be considered in pharmacoeconomic analyses. The cost of health-related productivity loss in psoriasis patients is unknown. Objective: To estimate the cost of productivity loss in psoriasis and its association with health-related quality of life and clinical disease severity. Methods: Cross-sectional study, recruitment of adult participants through Internet advertisements. 201 (72.3%) out of 278 eligible participants completed the study. Health-related work productivity loss, quality of life and clinical severity of psoriasis were assessed by standardized instruments. Results: Indirect costs of productivity loss clearly exceed the total direct cost. In contrast to objective clinical disease severity, health-related quality of life (measured by the Dermatology Life Quality Index) is an independent predictor of work productivity. Conclusions: There is good reason to believe that intervention can reduce health-related productivity loss by improving patients' quality of life. Savings from increased work productivity might offset comparatively high acquisition costs of biological agents.

Original languageEnglish (US)
Pages (from-to)102-110
Number of pages9
JournalDermatology
Volume213
Issue number2
DOIs
StatePublished - Aug 2006

Keywords

  • Absenteeism
  • Dermatology life quality index
  • Economic burden
  • Health economy
  • Presenteeism
  • Psoriasis

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis'. Together they form a unique fingerprint.

Cite this